Measuring Maternal and Neonatal Outcomes following Antenatal exposure to Methamphetamines in the Obstetric and Neonatal population cared for by the Women and Newborn Drug and Alcohol Service (WANDAS) at King Edward Memorial Hospital: A Mixed-Method Study

Angela O'Connor

Research output: ThesisDoctoral Thesis

57 Downloads (Pure)

Abstract

Methamphetamine (MA) is a potent neurostimulant which was the primary used illicit drug in pregnant women attending a Specialist Drug and Alcohol Service in Western Australia.
There is a paucity of literature related to the impact of MA use. The extent of the problems faced by women and their infants is poorly understood.
The research presented aims to measure the maternal and neonatal outcomes following prenatal exposure to MA. An explanatory sequential mixed-method design was used. Statistical analyses found that MA use has become a significant health problem in Western Australia, resulting in poor maternal and neonatal outcomes.
Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • The University of Western Australia
Supervisors/Advisors
  • Sachmann, Mark, Supervisor
  • Harris, Emma, Supervisor
  • Hamilton, Dale, Supervisor, External person
  • Fisher, Colleen, Supervisor
Thesis sponsors
Award date8 Feb 2021
DOIs
Publication statusUnpublished - 2020

Fingerprint

Dive into the research topics of 'Measuring Maternal and Neonatal Outcomes following Antenatal exposure to Methamphetamines in the Obstetric and Neonatal population cared for by the Women and Newborn Drug and Alcohol Service (WANDAS) at King Edward Memorial Hospital: A Mixed-Method Study'. Together they form a unique fingerprint.

Cite this